Aedifica/€AED
05:30
09:10
12:45
16:25
20:00
1D1W1MYTD1Y5YMAX
About Aedifica
Aedifica is a Belgian real estate investment trust (REIT) specializing in the healthcare real estate sector, particularly in elderly care homes. Founded in 2005 and headquartered in Brussels, Belgium, Aedifica's portfolio spans several European countries, including Belgium, the Netherlands, Germany, Finland, and the United Kingdom. The company focuses on acquiring, developing, and managing properties that meet the needs of Europe’s aging population, positioning itself strategically within the healthcare infrastructure space. Aedifica's competitive strengths lie in its specialization in a growing sector, comprehensive market knowledge, and long-standing relationships with care home operators. These capabilities enable it to effectively navigate the challenges and opportunities within the healthcare real estate market. Sources: Aedifica company website and annual reports.
Ticker
€AED
Sector
Primary listing
BSE
Employees
131
Headquarters
Website
Aedifica Metrics
BasicAdvanced
€3B
16.99
€3.70
0.94
€2.73
4.35%
Price and volume
Market cap
€3B
Beta
0.94
52-week high
€67.85
52-week low
€51.77
Average daily volume
65K
Dividend rate
€2.73
Financial strength
Current ratio
0.346
Quick ratio
0.161
Long term debt to equity
60.629
Total debt to equity
75.569
Dividend payout ratio (TTM)
105.58%
Interest coverage (TTM)
3.48%
Profitability
EBITDA (TTM)
306.546
Gross margin (TTM)
94.38%
Net profit margin (TTM)
48.65%
Operating margin (TTM)
83.97%
Effective tax rate (TTM)
12.71%
Revenue per employee (TTM)
€2,760,000
Management effectiveness
Return on assets (TTM)
2.96%
Return on equity (TTM)
4.95%
Valuation
Price to earnings (TTM)
16.985
Price to revenue (TTM)
8.263
Price to book
0.84
Price to tangible book (TTM)
0.86
Price to free cash flow (TTM)
10.247
Free cash flow yield (TTM)
9.76%
Free cash flow per share (TTM)
6.129
Dividend yield (TTM)
4.35%
Forward dividend yield
4.35%
Growth
Revenue change (TTM)
8.31%
Earnings per share change (TTM)
59.85%
3-year revenue growth (CAGR)
10.83%
3-year earnings per share growth (CAGR)
-30.96%
3-year dividend per share growth (CAGR)
1.56%
What the Analysts think about Aedifica
Majority rating from 16 analysts.
Bulls say / Bears say
Out of 15 analysts following Aedifica, nine rate the stock as “Buy” or “Strong Buy,” signaling broad confidence in its growth prospects (Reuters)
Barclays upgraded Aedifica to Overweight with a €74 price target, citing a revitalized growth strategy—raising its forecast for five-year EPS CAGR to 0.9% through increased acquisitions—and pointing to potential merger benefits with Cofinimmo (Reuters)
Aedifica has agreed to merge with Cofinimmo, creating Europe’s largest healthcare REIT with a combined €12.1 billion GAV and expected operational synergies of €16 million, accretive to EPRA EPS (Reuters)
Despite a 4% year-on-year increase in H1 EPRA EPS and 9% rental income growth, Aedifica kept its full-year 2025 guidance at €238 million, indicating that management anticipates limited upside beyond mid-single-digit growth (Investing.com)
Citi lowered Aedifica’s price target to €77.80, cautioning that the proposed all-share acquisition of Cofinimmo could dilute EPS by approximately 2% and NAV by about 6% by 2029, emphasizing risks related to integration and financing (Investing.com)
Aedifica’s debt-to-assets ratio increased to 42.4% as of June 2025 (up 60 basis points year-on-year), reducing leverage headroom and heightening refinancing risk as interest rates rise (Investing.com)
Data summarised monthly by Lightyear AI. Last updated on 6 Oct 2025.
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Market data provided by CBOE Europe and Deutsche Börse.
Capital at risk
Upcoming events
No upcoming events
FAQs
What’s the current market cap for Aedifica stock?
Aedifica (AED) has a market cap of €3B as of October 25, 2025.
What is the P/E ratio for Aedifica stock?
The price to earnings (P/E) ratio for Aedifica (AED) stock is 16.99 as of October 25, 2025.
Does Aedifica stock pay dividends?
Yes, the Aedifica (AED) stock pays dividends to shareholders. As of October 25, 2025, the dividend rate is €2.73 and the yield is 4.35%. Aedifica has a payout ratio of 105.58% on a trailing twelve-month basis.
When is the next Aedifica dividend payment date?
The next Aedifica (AED) dividend payment date is unconfirmed.
What is the beta indicator for Aedifica?
Aedifica (AED) has a beta rating of 0.94. This means that it is less volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 0.5 would mean it moves half as much as the market.